Quick Answer
A bipolar treatment review is a structured look at a plan that isn't working. It checks the diagnosis, whether medications were tried at adequate doses and levels, whether antidepressants may be destabilizing mood, and whether sleep, substances, thyroid problems or other conditions are blocking progress. It then considers approved options and adjustments.
Understanding bipolar Treatment Review
Bipolar depression can be stubborn. Some people try several medications and still struggle with low mood, low energy and hopelessness. When progress stalls, it’s worth stepping back to review the whole plan. A structured review looks at the diagnosis, every medication tried and how it was tried, and the factors that might be getting in the way. It’s not about blame. It’s about finding a better path. Many people who felt stuck improve after a review leads to a different combination or approach. This guide is part of Dr. Farkas's New York bipolar resources.
There are more options for bipolar depression than many people realize. A 2024 network meta-analysis in European Psychiatry reviewed the five FDA-approved antipsychotics for bipolar depression, cariprazine, lumateperone, lurasidone, olanzapine-fluoxetine and quetiapine, and noted that the CANMAT and ISBD guidelines list quetiapine and lurasidone among first-line choices. Lithium and lamotrigine also play central roles. A review checks which of these have been tried, at what doses and for how long. Our guide on tapering antidepressants in bipolar disorder covers one common adjustment.
For New Yorkers who’ve tried bipolar treatment without lasting relief, a structured review can turn frustration into a plan. NIMH reports that among adults with past-year bipolar disorder, the remaining 17.1% had moderate impairment, meaning nearly everyone affected faces real disruption. Secure video visits from anywhere in New York can make it easier to start bipolar care and keep regular follow-ups without extra travel.
Checking the bipolar diagnosis, medication trials and levels, and what might be blocking progress are the three parts of a review this guide covers.
Antidepressants and cycling
If someone with bipolar disorder takes an antidepressant without enough mood stabilization, it may contribute to mixed states or more frequent cycling, which can look like persistent depression. A review considers whether an antidepressant should be reduced or adjusted. Changes are made slowly, with mood stabilization in place.
What else might be blocking progress
Irregular sleep, heavy alcohol or cannabis use, ongoing stress, untreated medical problems and inconsistent medication use can all block recovery. Addressing them can unlock progress. Therapy focused on bipolar disorder, routines and family support also matter. The review looks at the whole life, not just medications.
Bipolar Treatment Review at a glance
| Question | Why it matters |
|---|---|
| Is the diagnosis complete? | Mixed features, ADHD, substances, borderline traits |
| Were trials adequate? | Dose, duration and blood levels |
| Are antidepressants destabilizing? | Cycling or mixed states |
| Thyroid and medical checks? | Low thyroid can mimic depression |
| Sleep and routines? | Irregular sleep blocks recovery |
Checking the bipolar diagnosis
Sometimes treatment stalls because the picture is more complicated. Depression with mixed features, ADHD, anxiety disorders, borderline personality features, PTSD, substance use or medical conditions can overlap with bipolar disorder and change what’s needed. A careful re-evaluation, sometimes with input from family, clarifies the picture. Thyroid function is checked, especially for people on lithium, since low thyroid can mimic depression.
Medication trials and levels
The review looks at each medication: the dose, how long it was taken, whether it was taken consistently and why it was stopped. For lithium, blood levels are reviewed, since a level below the target range may explain poor response. For lurasidone, taking it without enough food can sharply reduce absorption. For lamotrigine, estrogen-containing contraceptives can cut levels in half. Small practical issues like these sometimes explain a lot. Our guides on tapering antidepressants in bipolar disorder and the annual bipolar review cover related topics.
Bipolar treatment reviews for New York patients
Bipolar treatment reviews work well by secure video, with records and charts reviewed together. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.
Setting goals
A review is a chance to reset goals: steadier mood, more energy, returning to work, better sleep or fewer episodes. Clear goals help choose the next step and measure progress with mood charts and depression scores.
When to ask for a review
Ask for a review if you’ve been in treatment for several months without meaningful improvement, have tried several medications without success or feel stuck. A second opinion is reasonable. Thoughts of suicide need immediate help through 988 or 911. Stalled bipolar treatment is common, and many people improve after reassessment.
Bringing a full medication timeline, with doses, dates, blood levels and reasons for stopping, makes a review much more productive. Old pharmacy records or patient portals can help fill gaps.
Key Takeaways
- Persistent bipolar depression is a reason to review, not give up.
- Medication trials, doses and blood levels are checked.
- Antidepressants may be contributing to cycling in some people.
- Five antipsychotics are FDA-approved for bipolar depression.
The Bottom Line
Bipolar Treatment Review is common and treatable, and careful care can make daily life feel more manageable.
Frequently Asked Questions
What is a bipolar treatment review?
A bipolar treatment review is a structured look at a plan that isn't working. It checks the diagnosis and whether medications were tried at adequate doses and levels. It considers whether antidepressants may be destabilizing mood. It looks at sleep, substances and medical issues. The goal is a clear next step.
How many medications are approved for bipolar depression?
Five antipsychotics are FDA-approved for bipolar depression: cariprazine, lumateperone, lurasidone, olanzapine-fluoxetine and quetiapine. A 2024 review compared them. Lithium and lamotrigine also play central roles in bipolar care. Each has different trade-offs. A review checks which have been tried. An evaluation can clarify what's happening and which options fit.
Can practical issues explain why bipolar medication isn't working?
Yes, small practical issues can matter a lot. A lithium level below the target range may explain poor response. Taking lurasidone without enough food sharply reduces absorption. Estrogen-containing contraceptives can cut lamotrigine levels in half. A review checks for these. An evaluation can clarify what's happening and which options fit.
Can antidepressants make bipolar depression worse?
In some people with bipolar disorder, antidepressants without enough mood stabilization may contribute to mixed states or cycling. That can look like persistent depression. A review considers whether to reduce or adjust them. Changes are made slowly. Mood stabilization comes first. An evaluation can clarify what's happening and which options fit.
Is a second opinion reasonable for bipolar disorder?
Yes, a second opinion is reasonable if you feel stuck. A fresh perspective can clarify the diagnosis or suggest new options. Bring records of past medications, doses, levels and mood charts. Most clinicians welcome coordinated care. It's your right to seek another view. An evaluation can clarify what's happening and which options fit.
Can a bipolar treatment review happen by video in New York?
Yes, bipolar treatment reviews happen by secure video anywhere in New York. You need to be physically in New York during each visit. Records and mood charts can be reviewed together. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office. Self-pay fees are listed on the Good Faith Estimate page.
Where to go from here
- Right now, if you're not safe
- Call or text 988, or call 911.
- If you'd like an evaluation
- See how scheduling and telehealth work on the new patient page.
- If you want to keep reading
- Return to our full set of New York bipolar depression guides for more guides. For more help preparing and finding care, see NIMH’s tips for talking with your health care provider and FindTreatment.gov.
How We Reviewed This Page
Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.
What’s new: September 29, 2026. Page published.
References
- Efficacy and tolerability of FDA-approved atypical antipsychotics for bipolar depression: network meta-analysis. European Psychiatry (2024), via PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC10988162/
- LATUDA (lurasidone) Prescribing Information. https://www.latuda.com/LatudaPrescribingInformation.pdf
- National Institute of Mental Health. Bipolar Disorder statistics. https://www.nimh.nih.gov/health/statistics/bipolar-disorder
- 988 Suicide & Crisis Lifeline. https://988lifeline.org/
- Tips for talking with your health care provider. https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider
- FindTreatment.gov. https://findtreatment.gov/